Literature DB >> 10357452

Acquisition of fear conditioning in rats requires the synthesis of mRNA in the amygdala.

D J Bailey1, J J Kim, W Sun, R F Thompson, F J Helmstetter.   

Abstract

In this study, the role of mRNA synthesis in the amygdala was studied during the acquisition of conditional fear. Rats with cannulas placed in the basolateral region of the amygdala were trained with a series of noise-shock pairings in a distinctive observation chamber. One half of the rats were pretreated with the mRNA synthesis inhibitor actinomycin-D (act-D). Responding to the training context and the auditory stimulus in a novel context measured by defensive freezing was assessed. Pretreatment with act-D significantly attenuated fear responses to both stimuli. Animals receiving act-D injections exhibited normal reactions to the conditioned stimulus-unconditioned stimulus pairings in the initial training session and displayed normal learning when retrained 7 days after injections. These results indicate that the transcription of new mRNA and subsequent protein synthesis in the amygdala may be essential for neural plasticity during this form of associative learning.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10357452     DOI: 10.1037//0735-7044.113.2.276

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  54 in total

1.  Activation of ERK/MAP kinase in the amygdala is required for memory consolidation of pavlovian fear conditioning.

Authors:  G E Schafe; C M Atkins; M W Swank; E P Bauer; J D Sweatt; J E LeDoux
Journal:  J Neurosci       Date:  2000-11-01       Impact factor: 6.167

2.  Regulation of synaptic plasticity genes during consolidation of fear conditioning.

Authors:  Kerry J Ressler; Gayla Paschall; Xiao-liu Zhou; Michael Davis
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

3.  Memory consolidation in both trace and delay fear conditioning is disrupted by intra-amygdala infusion of the protein synthesis inhibitor anisomycin.

Authors:  Janine L Kwapis; Timothy J Jarome; Janet C Schiff; Fred J Helmstetter
Journal:  Learn Mem       Date:  2011-10-25       Impact factor: 2.460

4.  The timing of multiple retrieval events can alter GluR1 phosphorylation and the requirement for protein synthesis in fear memory reconsolidation.

Authors:  Timothy J Jarome; Janine L Kwapis; Craig T Werner; Ryan G Parsons; Georgette M Gafford; Fred J Helmstetter
Journal:  Learn Mem       Date:  2012-06-20       Impact factor: 2.460

5.  The formation of auditory fear memory requires the synthesis of protein and mRNA in the auditory thalamus.

Authors:  R G Parsons; B A Riedner; G M Gafford; F J Helmstetter
Journal:  Neuroscience       Date:  2006-06-12       Impact factor: 3.590

6.  Long-term stability of fear memory depends on the synthesis of protein but not mRNA in the amygdala.

Authors:  Ryan G Parsons; Georgette M Gafford; David E Baruch; Brady A Riedner; Fred J Helmstetter
Journal:  Eur J Neurosci       Date:  2006-04       Impact factor: 3.386

7.  Distribution of NMDA and AMPA receptor subunits at thalamo-amygdaloid dendritic spines.

Authors:  Jason J Radley; Claudia R Farb; Yong He; William G M Janssen; Sarina M Rodrigues; Luke R Johnson; Patrick R Hof; Joseph E LeDoux; John H Morrison
Journal:  Brain Res       Date:  2007-01-17       Impact factor: 3.252

Review 8.  The role of protein synthesis in memory consolidation: progress amid decades of debate.

Authors:  Pepe J Hernandez; Ted Abel
Journal:  Neurobiol Learn Mem       Date:  2007-11-28       Impact factor: 2.877

9.  Transgenic mice expressing an inhibitory truncated form of p300 exhibit long-term memory deficits.

Authors:  Ana M M Oliveira; Marcelo A Wood; Conor B McDonough; Ted Abel
Journal:  Learn Mem       Date:  2007-08-29       Impact factor: 2.460

10.  Intra-amygdala muscimol injections impair freezing and place avoidance in aversive contextual conditioning.

Authors:  Matthew R Holahan; Norman M White
Journal:  Learn Mem       Date:  2004-07-14       Impact factor: 2.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.